Biomarker profile in stable Fontan patients
Authors:
- 1 April 2020
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 305, 56-62
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association (15POST22780002)
- NIH Research Service Award (F32HL126321)
- Warshaw Fellow Research Award
- K23 (HL128795)
- Brock Translational Fund
- Woodruff Foundation
This publication has 50 references indexed in Scilit:
- Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heartInternational Journal of Cardiology, 2013
- MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgeryHeart, 2013
- Congenital heart disease and the liverHepatology, 2012
- Atrial tachyarrhythmias late after Fontan operation are related to increase in mortality and hospitalizationInternational Journal of Cardiology, 2012
- Biomarkers in Heart FailureNew England Journal of Medicine, 2008
- VEGF‐D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinomaInternational Journal of Cancer, 2008
- An overview of tumor necrosis factor α and the failing human heartCurrent Opinion in Cardiology, 1999
- Increased levels of serum neoprotein and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alphaJACC, 1993
- Tumour necrosis factor alpha in severe congestive cardiac failure.Heart, 1993
- Significance of Serum Type-IV Collagen Levels in Various Liver Diseases Measurement with a One-Step Sandwich Enzyme Immunoassay Using Monoclonal Antibodies with Specificity for Pepsin-Solubilized Type-IV CollagenScandinavian Journal of Gastroenterology, 1992